Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weina Han

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Frontiers in Pharmacology|February 11, 2020
Kang Le Xin Reduces Blood Pressure Through Inducing Endothelial-Dependent Vasodilation by Activating the AMPK-eNOS PathwayYixiu Zhao, Jiuxin Zhu, Hangfei Liang, et al.
Biochemical Pharmacology|June 23, 2024
Tetrahydroberberrubine exhibits preventive effect on obesity by activating PGC1α-mediated thermogenesis in white and brown adipose tissueXueqing Tang, Yang Shi, Yongchao Chen, et al.
European Journal of Pharmacology|June 9, 2023
Tetrahydroberberrubine prevents peritoneal adhesion by suppressing inflammation and extracellular matrix accumulationHeng Liu, Henghui Xu, Heyang Sun, et al.
Journal of Advanced Research|November 23, 2025
Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitorRun Xu, Xutong Wang, Jin Gao, et al.
European Journal of Pharmacology|January 4, 2025
Tetrahydroberberrubine improves hyperlipidemia by activating the AMPK/SREBP2/PCSK9/LDL receptor signaling pathwayJing Feng, Run Xu, Zijia Dou, et al.
Acta Pharmaceutica Sinica. B|January 1, 2026
THBru ameliorates atherosclerosis by inhibiting endothelial ferroptosis <i>via</i> regulation of the super-enhancer-associated <i>ABCC1</i>Jing Feng, Yingying Hu, Xiuxiu Sun, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Frontiers in Pharmacology|February 11, 2020
Kang Le Xin Reduces Blood Pressure Through Inducing Endothelial-Dependent Vasodilation by Activating the AMPK-eNOS PathwayYixiu Zhao, Jiuxin Zhu, Hangfei Liang, et al.
Biochemical Pharmacology|June 23, 2024
Tetrahydroberberrubine exhibits preventive effect on obesity by activating PGC1α-mediated thermogenesis in white and brown adipose tissueXueqing Tang, Yang Shi, Yongchao Chen, et al.
European Journal of Pharmacology|June 9, 2023
Tetrahydroberberrubine prevents peritoneal adhesion by suppressing inflammation and extracellular matrix accumulationHeng Liu, Henghui Xu, Heyang Sun, et al.
Journal of Advanced Research|November 23, 2025
Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitorRun Xu, Xutong Wang, Jin Gao, et al.
European Journal of Pharmacology|January 4, 2025
Tetrahydroberberrubine improves hyperlipidemia by activating the AMPK/SREBP2/PCSK9/LDL receptor signaling pathwayJing Feng, Run Xu, Zijia Dou, et al.
Acta Pharmaceutica Sinica. B|January 1, 2026
THBru ameliorates atherosclerosis by inhibiting endothelial ferroptosis <i>via</i> regulation of the super-enhancer-associated <i>ABCC1</i>Jing Feng, Yingying Hu, Xiuxiu Sun, et al.
Pageof 6